|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 July 2001, Vol. 98, No. 1, pp. 130-139
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Immunodominant epitopes on glycoprotein IIb-IIIa recognized by
autoreactive T cells in patients with immune
thrombocytopenic purpura
Masataka Kuwana,
Junichi Kaburaki,
Hidero Kitasato,
Miyako Kato,
Shinichi Kawai,
Yutaka Kawakami, and
Yasuo Ikeda
From the Institute for Advanced Medical Research and
the Department of Internal Medicine, Keio University School of
Medicine, Tokyo; the Department of Internal Medicine, Tokyo Electric
Power Company Hospital; the Department of Microbiology, Kitasato
University School of Medicine, Sagamihara; and the Institute of Medical
Science, St Marianna University School of Medicine, Kawasaki, Japan.
It was recently reported that autoreactive CD4+ T cells
to glycoprotein IIb-IIIa (GPIIb-IIIa) mediate antiplatelet autoantibody production in patients with immune thrombocytopenic purpura (ITP). To
further examine the antigenic specificity of the GPIIb-IIIa-reactive T
cells, 6 recombinant fragments encoding different portions of GPIIb
or GPIIIa were generated and tested for their ability to stimulate
antigen-specific T-cell proliferation and anti-GPIIb-IIIa antibody
production in vitro. T cells from the peripheral blood of 25 patients
with ITP and 10 healthy donors proliferated in response to recombinant
GPIIb-IIIa fragments in various combinations. The amino-terminal
portions of both GPIIb and GPIIIa (IIb 18-259 and IIIa22-262) were
frequently recognized (60% and 64%, respectively) compared with other
fragments (4%-28%) in patients with ITP, but this tendency was not
detected in healthy donors. In subsequent analyses in patients
with ITP, T-cell reactivities to IIb 18-259 and IIIa22-262 were
consistently detected, whereas those to other fragments were sometimes
lost. In vitro antigenic stimulation of peripheral blood mononuclear
cells with IIb 18-259 or IIIa22-262 promoted the synthesis of
anti-GPIIb-IIIa antibodies in patients with ITP, but not in healthy
donors. Of 15 CD4+ T-cell lines specific for
platelet-derived GPIIb-IIIa generated from 5 patients with ITP, 13 lines recognized IIb 18-259, IIIa22-262, or both. T-cell lines
reactive to IIb 18-259 or IIIa22-262 promoted the production of
anti-GPIIb-IIIa antibodies that were capable of binding to normal
platelet surfaces. These results indicate that the immunodominant
epitopes recognized by pathogenic CD4+ T cells in patients
with ITP are located within the amino-terminal portions of both
GPIIb and GPIIIa.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Yu, S. Heck, V. Patel, J. Levan, Y. Yu, J. B. Bussel, and K. Yazdanbakhsh
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura
Blood,
August 15, 2008;
112(4):
1325 - 1328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sukati, H. G. Watson, S. J. Urbaniak, and R. N. Barker
Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura
Blood,
May 15, 2007;
109(10):
4528 - 4538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sakakura, H. Wada, Y. Abe, J. Nishioka, H. Tomatsu, Y. Hamaguchi, S. Oguni, H. Shiku, and T. Nobori
Usefulness of Measurement of Reticulated Platelets for Diagnosis of Idiopathic Thrombocytopenic Purpura
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2005;
11(3):
253 - 261.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. P. Panitsas, M. Theodoropoulou, A. Kouraklis, M. Karakantza, G. L. Theodorou, N. C. Zoumbos, A. Maniatis, and A. Mouzaki
Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response
Blood,
April 1, 2004;
103(7):
2645 - 2647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kuwana, S. Nomura, K. Fujimura, T. Nagasawa, Y. Muto, Y. Kurata, S. Tanaka, and Y. Ikeda
Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura
Blood,
February 15, 2004;
103(4):
1229 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takenaka and H. Suzuki
Lixelle ameliorates idiopathic thrombocytopenic purpura
Nephrol. Dial. Transplant.,
May 1, 2003;
18(5):
1032 - 1033.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kuwana, Y. Kawakami, and Y. Ikeda
Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura
Blood,
January 15, 2003;
101(2):
621 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kuwana, Y. Okazaki, J. Kaburaki, Y. Kawakami, and Y. Ikeda
Spleen Is a Primary Site for Activation of Platelet-Reactive T and B Cells in Patients with Immune Thrombocytopenic Purpura
J. Immunol.,
April 1, 2002;
168(7):
3675 - 3682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Cines and V. S. Blanchette
Immune Thrombocytopenic Purpura
N. Engl. J. Med.,
March 28, 2002;
346(13):
995 - 1008.
[Full Text]
[PDF]
|
 |
|
| |